References
- Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146:S1–35.
- Chau JK, Lin JRJ, Atashband S, Irvine RA, Westerberg BD. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope 2010;120:1011–21.
- Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463–80.
- Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980;106:772–6.
- Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008;29:453–60.
- Ernst E. Therapeutic defibrinogenation in peripheral vascular disease. Int Angiol 1985;4:373–7.
- Stocker K. Defibrinogenation with thrombin-like snake venom enzymes. In: Born GVR, Eichler O, Herken A, editors. Handbook experimental pharmacology: fibrinolytics and antifibrinolytics. New York, NY: Springer-Verlag; 1978. pp 451–84.
- Stocker K, Fischer H, Meier J. Thrombin-like snake venom proteinases. Toxicon 1982;20:265–73.
- Kubo T, Matsunaga T, Asai H, Kawamoto K, Kusakari J, Nomura Y, et al. Efficacy of defibrinogenation and steroid therapies on sudden deafness. Arch Otolaryngol Head Neck Surg 1988;114:649–52.
- Shiraishi T, Kubo T, Okumura S, Naramura H, Nishimura M, Okusa M, et al. Hearing recovery in sudden deafness patients using a modified defibrinogenation therapy. Acta Otolaryngol (Suppl.) 1992;501:46–50.
- Suzuki H, Furukawa M, Kumagami M, Takahashi E, Matsuura K, Katori Y, et al. Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy. Acta Otolaryngol 2003;123:46–50.
- Ihler F, Strieth S, Pieri N, Göhring P, Canis M. Acute hyperfibrinogenemia impairs cochlear blood flow and hearing function in guinea pigs in vivo. Int J Audiol 2012;51:210–5.
- Kawakami M, Makimoto K, Yamamoto H, Takahashi H. The effect of batroxobin on cochlear blood flow. Acta Otolaryngol 1992;112:991–7.
- Nakashima T, Tanabe T, Yanagita N, Wakai K, Ohno Y. Risk factors for sudden deafness: a case-control study. Auris Nasus Larynx 1997;24:265–70.
- Ohinata Y, Makimoto K, Kawakami M, Haginomori S, Araki M, Takahashi H. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol 1994;114:601–7.
- Suckfüll M, Wimmer C, Reichel O, Mees K, Schorn K. Hyperfibrinogenemia as a risk factor for sudden hearing loss. Otol Neurotol 2002;23:309–11.
- Kanzaki S, Sakagami M, Hosoi H, Murakami S, Ogawa K. High fibrinogen in peripheral blood correlates with poorer hearing recovery in idiopathic sudden sensorineural hearing loss. PLoS One 2014;9:e104680.
- Wittig J, Wittekindt C, Kiehntopf M, Guntinas-Lichius O. Prognostic impact of standard laboratory values on outcome in patients with sudden sensorineural hearing loss. BMC Ear Nose Throat Disord 2014;14:6.
- Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 1996;17:529–36.